Discontinuation report LOPRESOR SR 200 MG
| Report ID | 128062 |
| Drug Identification Number | 00534560 |
| Brand name | LOPRESOR SR 200 MG |
| Common or Proper name | LOPRESOR SR 200MG 250'S |
| Company Name | NOVARTIS PHARMACEUTICALS CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METOPROLOL TARTRATE |
| Strength(s) | 200MG |
| Dosage form(s) | TABLET (EXTENDED-RELEASE) |
| Route of administration | ORAL ORAL |
| Packaging size | 250'S |
| ATC code | C07AB |
| ATC description | BETA BLOCKING AGENTS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | |
| Actual discontinuation date | 2020-02-06 |
| Remaining supply date | 2020-02-06 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | Inventory depleted |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 700 RUE SAINT-HUBERT MONTREAL, QUEBEC CANADA H2Y 0C1 |
| Company contact information | [email protected] |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v2 | 2020-11-06 | French | Compare |
| v1 | 2020-11-06 | English | Compare |
Showing 1 to 2 of 2